Key result
Breast cancer chemotherapy alone is linked to ~5-fold higher heart disease mortality at 10+ years.
Why the study?
The long-term risk of death from heart disease among breast cancer patients was unknown despite heart disease being a leading cause of death.
Does breast cancer treatment (chemotherapy and/or radiotherapy) increase the long-term risk of fatal heart disease in breast cancer patients?
Cohort (n=1,059,048)
Yes
Does breast cancer treatment (chemotherapy and/or radiotherapy) increase the long-term risk of fatal heart disease in breast cancer patients?
Effect estimate: SMR 5.05 (95% CI 4.57-5.55)
p-value: p=<0.001
Breast cancer survivors, particularly older women with longer follow-up who received chemotherapy, have a significantly increased risk of fatal heart disease, highlighting the need for dedicated cardio-oncology care.
May warrant extended cardiac surveillance in chemotherapy-treated breast cancer survivors; hypothesis-generating and requires prospective confirmation.
Background: Most breast cancer patients die of non-cancer causes. The risk of death from heart disease, a leading cause of death, is unknown. The aim of this study is to characterize the long-term risk of fatal heart disease in breast cancer patients. Methods: This retrospective study used the Surveillance, Epidemiology, and End Results (SEER) database. Standard mortality ratios (SMR) were calculated for breast cancer patients diagnosed from 1992 to 2014. Patients were stratified by receipt of radiotherapy and/or chemotherapy, disease laterality, and diagnosis era. Hazard ratios (HRs) and odds ratios (ORs) were calculated to compare the risk of death from heart disease among other breast cancer patients. Results: < 0.001). There was no statistically significant difference in SMR for death from heart disease for left-sided vs. right-sided disease. At 10+ years, heart disease made up 28% of deaths from non-primary cancer. HRs and ORs showed that the risk of death from heart disease was highest in patients older than 70 years of age and with longer follow-up. Conclusion: The risk of fatal heart disease was highest in older breast cancer patients with longer follow-up (i.e., >5-10 years) and who received chemotherapy. These patients should be referred to cardio-oncology clinics to mitigate this risk.
No takes yet. Share an insight, caveat, or question.
Agha et al. (2022) conducted a cohort in Breast cancer (n=1,059,048). Chemotherapy vs. General United States population was evaluated on Standard mortality ratio for death from heart disease at 10+ years (SMR 5.05, 95% CI 4.57-5.55, p=<0.001). Breast cancer patients who received only chemotherapy had a significantly increased risk of death from heart disease at 10 or more years of follow-up, with a standard mortality ratio of 5.05 compared to the general population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: